Literature DB >> 499007

Potassium replacement: supplements or potassium-sparing diuretics?

T O Morgan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 499007     DOI: 10.2165/00003495-197918030-00004

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  6 in total

Review 1.  Diuretics: mechanism of action and clinical application.

Authors:  D L Davies; G M Wilson
Journal:  Drugs       Date:  1975       Impact factor: 9.546

2.  The effects of potassium supplements, spironolactone of amiloride on the potassium status of patients with heart failure.

Authors:  C Davidson; L Burkinshaw; D B Morgan
Journal:  Postgrad Med J       Date:  1978-06       Impact factor: 2.401

3.  Diuretics: basic clinical pharmacology and therapeutic use.

Authors:  T O Morgan
Journal:  Drugs       Date:  1978-02       Impact factor: 9.546

4.  Diuretics, cardiac failure and potassium depletion: a rational approach.

Authors:  C Whight; T Morgan; S Carney; M Wilson
Journal:  Med J Aust       Date:  1974-12-07       Impact factor: 7.738

5.  A comparison of the effects of hydrochlorothiazide and of frusemide in the treatment of hypertensive patients.

Authors:  J Anderson; B E Godfrey; D M Hill; A D Munro-Faure; J Sheldon
Journal:  Q J Med       Date:  1971-10

6.  Sodium restriction and thiazide diuretics in the treatment of hypertension.

Authors:  S Carney; T Morgan; M Wilson; G Matthews; R Roberts
Journal:  Med J Aust       Date:  1975-06-28       Impact factor: 7.738

  6 in total
  2 in total

Review 1.  Drug-induced electrolyte abnormalities.

Authors:  E P Brass; W L Thompson
Journal:  Drugs       Date:  1982-09       Impact factor: 9.546

2.  Single and divided daily dose piretanide in the treatment of uncomplicated essential hypertension: a double-blind comparison with a combination of hydrochlorothiazide and amiloride.

Authors:  M Verho; B Rangoonwala; W Dols
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.